The proof is in the data
Twist Biopharma is a trusted partner with a proven track record for developing superior antibody leads with drug like developability profiles
Discovering High-Affinity, Functional Anti-GPCR Antibodies
Read how Twist’s Synthetic Libraries were designed and used to identify GLP-1R antagonistic antibodies.
Achieving large-scale antibody affinity maturation
Learn how the Twist Antibody Optimization (TAO) service dramatically improved the affinity of an anti-PD1 antibody.
Candidates recapitulated Beacon binding profiles as recombinantly expressed antibodies
Read about rapid discovery of rare, specific antibodies against a cell surface target.
Deep analysis allows for the final selection of leads using epitope binning and neutralization data
Read about enhanced epitopic coverage with a diverse range of affinity via DiversimAb and humanzied mice.
